Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCPH
2026
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $9.71M | ﹤0.01% |
285,630
+8,877
| +3% | +$283K |
|
|
CAI
2027
DELISTED
CAI International, Inc.
CAI
| $9.71M | ﹤0.01% |
173,569
-6,267
| -3% | -$350K |
|
2028
Ocugen
OCGN
$458M
| $9.7M | ﹤0.01% |
1,351,120
+883,662
| +189% | +$6.49M |
|
2029
e.l.f. Beauty
ELF
$5.43B
| $9.67M | ﹤0.01% |
332,815
+51,083
| +18% | +$1.46M |
|
2030
Telos
TLS
$344M
| $9.66M | ﹤0.01% |
339,803
+185,796
| +121% | +$5.59M |
|
2031
The Joint Corp
JYNT
$119M
| $9.66M | ﹤0.01% |
98,506
+64,573
| +190% | +$6.04M |
|
2032
Supernus Pharmaceuticals
SUPN
$2.74B
| $9.65M | ﹤0.01% |
362,005
-56,535
| -14% | -$1.52M |
|
2033
Hydrofarm Holdings
HYFM
$8.58M
| $9.65M | ﹤0.01% |
25,491
+16,314
| +178% | +$7.92M |
|
|
CTEV
2034
Claritev Corp
CTEV
$716M
| $9.65M | ﹤0.01% |
42,832
-23,580
| -36% | -$6.38M |
|
|
MRC
2035
DELISTED
MRC Global
MRC
| $9.63M | ﹤0.01% |
1,312,561
-366
| -0% | -$3.04K |
|
2036
ProPetro Holding
PUMP
$1.42B
| $9.63M | ﹤0.01% |
1,113,215
+74,729
| +7% | +$584K |
|
|
TA
2037
DELISTED
TravelCenters of America LLC
TA
| $9.62M | ﹤0.01% |
193,109
+57,514
| +42% | +$2.15M |
|
|
SUMO
2038
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $9.61M | ﹤0.01% |
596,114
+346,698
| +139% | +$6.89M |
|
2039
Codexis
CDXS
$175M
| $9.57M | ﹤0.01% |
411,582
+13,362
| +3% | +$316K |
|
|
MORF
2040
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $9.53M | ﹤0.01% |
168,217
+54,061
| +47% | +$3.27M |
|
2041
CTS Corp
CTS
$1.79B
| $9.51M | ﹤0.01% |
307,490
+1,665
| +0.5% | +$57K |
|
|
PGTI
2042
DELISTED
PGT, Inc.
PGTI
| $9.5M | ﹤0.01% |
497,521
+39,366
| +9% | +$841K |
|
2043
Customers Bancorp
CUBI
$2.82B
| $9.48M | ﹤0.01% |
220,326
-91,551
| -29% | -$3.56M |
|
2044
Yext
YEXT
$613M
| $9.48M | ﹤0.01% |
787,661
+76,592
| +11% | +$987K |
|
|
NXGN
2045
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $9.46M | ﹤0.01% |
670,504
+10,867
| +2% | +$169K |
|
2046
MacroGenics
MGNX
$259M
| $9.42M | ﹤0.01% |
450,030
-454
| -0.1% | -$10.9K |
|
2047
Ryan Specialty Holdings
RYAN
$11B
| $9.42M | ﹤0.01% |
+278,142
| New | +$8.77M |
|
2048
SentinelOne
S
$8.17B
| $9.39M | ﹤0.01% |
+175,360
| New | +$9.63M |
|
|
TSP
2049
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $9.38M | ﹤0.01% |
252,649
+18,063
| +8% | +$761K |
|
2050
Perdoceo Education
PRDO
$1.99B
| $9.38M | ﹤0.01% |
888,183
+51,395
| +6% | +$578K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.